Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval

CNBC Markets

·

Original Report

↗ CNBC Markets

Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity.